HC Wainwright Issues Pessimistic Outlook for ZVRA Earnings
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Research analysts at HC Wainwright cut their FY2025 earnings estimates for shares of Zevra Therapeutics in a note issued to investors on Thursday, March 13th. HC Wainwright analyst O. Livnat now anticipates that the company will post earnings of ($0.32) per share for the year, down from […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Research analysts at HC Wainwright cut their FY2025 earnings estimates for shares of Zevra Therapeutics in a note issued to investors on Thursday, March 13th. HC Wainwright analyst O. Livnat now anticipates that the company will post earnings of ($0.32) per share for the year, down from […]
